[Purulent meningitis from a bacteriological viewpoint].
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002228:Carbenicillin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D004926:Escherichia coli / Q000302:isolation & purification; D005839:Gentamicins / Q000627:therapeutic use; D006190:Haemophilus / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000382:microbiology; D008297:Male; D008581:Meningitis / Q000382:microbiology*; D009345:Neisseria meningitidis / Q000302:isolation & purification; D010403:Penicillin Resistance; D013296:Streptococcus pneumoniae / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002701:Chloramphenicol; D000667:Ampicillin; D002228:Carbenicillin
Meningitis purulenta aus bakteriologischer Sicht.